We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $1.21T
1-Year Est. Return 78.12%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+78.12%
3 Year Est. Return
+206.85%
5 Year Est. Return
+219.98%
10 Year Est. Return
+889.43%
AUM
$662B
AUM Growth
+$5B
Cap. Flow
+$924M
Cap. Flow %
0.14%
Top 10 Hldgs %
34.26%
Holding
12,943
New
2,363
Increased
4,318
Reduced
4,192
Closed
1,998

Sector Composition

Rank Sector Weight
1 Technology 2.77%
2 Healthcare 1.08%
3 Consumer Discretionary 1.03%
4 Financials 0.94%
5 Communication Services 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSYS icon
10051
PUT
Stratasys
SSYS
$781M
$122K ﹤0.01%
14,100
-14,700
-51% -$146K
EMBC icon
10052
PUT
Embecta
EMBC
$289M
$122K ﹤0.01%
+10,300
New +$136K
CODA icon
10053
Coda Octopus Group
CODA
$119M
$122K ﹤0.01%
+13,152
New +$119K
AMLX icon
10054
PUT
Amylyx Pharmaceuticals
AMLX
$2.41B
$122K ﹤0.01%
+10,100
New +$137K
FDMT icon
10055
CALL
4D Molecular Therapeutics
FDMT
$673M
$122K ﹤0.01%
16,200
-8,300
-34% -$84.2K
LPCVU
10056
Launchpad Cadenza Acquisition Corp I Unit
LPCVU
$121K ﹤0.01%
+12,137
New +$121K
NIXX
10057
Nixxy Inc
NIXX
$19.7M
$121K ﹤0.01%
+126,018
New +$169K
CRVS icon
10058
PUT
Corvus Pharmaceuticals
CRVS
$1.25B
$121K ﹤0.01%
+15,700
New +$124K
GROY icon
10059
CALL
Gold Royalty Corp
GROY
$727M
$121K ﹤0.01%
29,900
-22,000
-42% -$84.2K
CNH
10060
PUT
CNH Industrial
CNH
$16.8B
$121K ﹤0.01%
+13,100
New +$131K
UNCY icon
10061
CALL
Unicycive Therapeutics
UNCY
$153M
$121K ﹤0.01%
+20,900
New +$112K
MAIA icon
10062
MAIA Biotechnology
MAIA
$85.2M
$120K ﹤0.01%
+78,757
New +$103K
FMN
10063
Federated Hermes Premier Municipal Income Fund
FMN
$87.5M
$120K ﹤0.01%
+10,840
New +$120K
VYX icon
10064
PUT
NCR Voyix
VYX
$1.13B
$120K ﹤0.01%
11,800
-51,400
-81% -$558K
HIMY
10065
DELISTED
Defiance Leveraged Long Income HIMS ETF
HIMY
$120K ﹤0.01%
18,463
+8,813
+91% +$116K
BAIG
10066
CALL
Leverage Shares 2X Long BBAI Daily ETF
BAIG
$9.49M
$120K ﹤0.01%
1,380
+300
+28% +$48.5K
ORGN
10067
DELISTED
Origin Materials
ORGN
$120K ﹤0.01%
18,858
+17,784
+1,656% +$260K
LXRX icon
10068
CALL
Lexicon Pharmaceuticals
LXRX
$1.03B
$120K ﹤0.01%
+104,100
New +$143K
SNDL icon
10069
CALL
Sundial Growers
SNDL
$313M
$120K ﹤0.01%
72,100
-4,500
-6% -$9.03K
RPTX
10070
PUT
DELISTED
Repare Therapeutics
RPTX
$120K ﹤0.01%
+46,000
New +$92.6K
PC
10071
Premium Catering Holdings
PC
$120K ﹤0.01%
12,723
+1,762
+16% +$17.7K
TDAY
10072
CALL
USA Today Co
TDAY
$1.03B
$119K ﹤0.01%
23,200
-15,900
-41% -$74.7K
BRSP
10073
BrightSpire Capital
BRSP
$633M
$119K ﹤0.01%
21,320
-146,083
-87% -$804K
BBDC icon
10074
CALL
Barings BDC
BBDC
$975M
$119K ﹤0.01%
+13,000
New +$115K
LGCY
10075
Legacy Education Inc
LGCY
$136M
$119K ﹤0.01%
11,711
-11,063
-49% -$106K

Similar funds

Jane Street's Q4 2025 Portfolio in Review

As of Q4 2025, Jane Street held 12,943 positions worth $662B, up 0.76% from $657B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jane Street's Q4 2025 filing shows 2,363 new, 4,318 increased, 4,192 reduced and 1,998 closed positions. Its largest new stake was iShares MSCI India ETF: 4,400,850 shares worth $238M. The largest sale was NVIDIA, an estimated $1.99B.

By sector, the portfolio is most concentrated in Technology at 2.8% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jane Street's largest Q4 2025 buy was iShares MSCI India ETF: 4,400,850 shares worth $238M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $5.55B increase.
  • Jane Street's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.99B.
  • Jane Street fully exited Applied Digital in Q4 2025, selling an estimated $207M.
  • Jane Street's ten largest holdings make up 34% of its $662B portfolio in Q4 2025.
  • Jane Street opened 2,363 new positions and closed 1,998 in Q4 2025.
  • Jane Street's portfolio value rose 0.76% quarter-over-quarter to $662B.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.